Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Teucrium Soybean Fund (SOYB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Teucrium Soybean Fund — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $111.12 (market cap $12.58B), while Teucrium Soybean Fund trades at $27.55 (market cap $43.52M). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 289.1× Teucrium Soybean Fund's market cap, and Teucrium Soybean Fund is more actively traded (32,585 versus 2,179,278). Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Teucrium Soybean Fund for 23 Days on average.
| HALO | SOYB | |
|---|---|---|
Market Cap | $12.58B | $43.52M |
Volume | 2,179,278 | 32,585 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $115.22 | $28.14 |
52-Week Low | $61.63 | $21.55 |
Typical Hold Time | 1 Days | 23 Days |
Enterprise Value | $14.49B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Teucrium Soybean Fund
SOYB is a commodity ETF that provides exposure to the price of soybean futures. It utilizes a laddered strategy by investing in several benchmark futures contracts to reduce the impact of roll costs and contango in the agricultural market.
Read more on SOYB →
